Genewiz, Hy Laboratories Partner
News May 29, 2015
The multiyear project seeks to stratify patients with diabetes and obesity for bariatric surgery or alternative treatments. Obesity and diabetes are closely related to the function and population of the gut microbiome, the firms said in a statement.
"With access to Hy Labs' patient network, we will target the most relevant microbiota in the gut system via stool sample collection and medical metadata to detect and determine the relative abundance of bacterial and archaeal species," Shihong Li, Genewiz manager of R&D, said in a statement. "We will apply Genewiz's proprietary next-generation sequencing methodologies on both the Illumina MiSeq and Thermo Fisher Scientific's Ion PGM to capture increased sequence diversity with a very high level of sensitivity."
The tests will be used in a clinical study conducted in the US and at Kaplan Medical Center in Rehovot, Israel.
The collaboration is funded with a grant from the Israel-US Binational Industrial Research and Development Foundation, the firms said in a statement. The amount of the grant was not disclosed.
Retrained Enzyme is Biocatalysis MilestoneNews
TU Graz researchers managed for the first time ever to ‘retrain’ an enzyme to build ring-shaped molecular structures instead of performing its natural task of reducing double bonds. The work was published in Angewandte Chemie, and is relevant for the production of pharmaceuticals and plant protection products.
Laser Pulses and Fluorescence Enable Metabolite ViewingNews
In the search for new sources of drugs, biodegradables and biofuels scientists have come to realize that life itself could be the solution, using natural metabolites produced by bacteria to produce vital compounds like penicillin. Identifying which cells are most useful for this goal has proved a huge challenge, but a new system using fluorescence and lasers has enabled metabolite viewing in real time in algae cells.READ MORE